NASDAQ:VIVO Meridian Bioscience (VIVO) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free VIVO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$33.97▼$33.9750-Day Range$33.00▼$33.9752-Week Range$20.35▼$34.38VolumeN/AAverage Volume973,737 shsMarket Capitalization$1.50 billionP/E Ratio35.02Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Meridian Bioscience alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About Meridian Bioscience Stock (NASDAQ:VIVO)Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. Its platforms include molecular, immunoassay, urea breath, and blood chemistry. It operates through the Diagnostics and Life Science segments. The Diagnostics segment consists of manufacturing operations for infectious disease and blood chemistry products and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment distributes bulk antigens, antibodies, polymerase chain reaction/ quantitative PCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.Read More Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). VIVO Stock News HeadlinesFebruary 8, 2024 | health.usnews.comMeridian Meadows Transitional CareNovember 28, 2023 | benzinga.comMeridian Bioscience Earns EcoVadis Bronze Medal in Recognition of Its Dedication to SustainabilityApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.July 25, 2023 | finance.yahoo.comMeridian Bioscience Continues Expansion of H. pylori Diagnostic Testing Solutions with FDA Clearance of Premier HpSA FlexMay 17, 2023 | marketwatch.comRapid Testing Kits Market Size Opportunities, Top Countries Data, Future Trends and Share Forecast 2028April 27, 2023 | marketwatch.comRapid Testing Kits Market Size with Growth Opportunities, Top Countries Data, Future Trends and Share with Revenue Forecast 2028April 19, 2023 | thestreet.comMeridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO)April 19, 2023 | markets.businessinsider.comMeridian Bioscience Announces FDA Clearance for Innovative Curian® Shiga Toxin AssayApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 6, 2023 | bizjournals.comFormer executives at Meridian Bioscience subsidiary facing federal chargesApril 5, 2023 | markets.businessinsider.comMeridian Bioscience Comments on DOJ Announcement Regarding Former Executives of Magellan DiagnosticsMarch 30, 2023 | thestreet.comMeridian Bioscience Stock Hits New 52-Week Low (VIVO)March 26, 2023 | thestreet.comMeridian Bioscience Stock Hits New 52-Week High (VIVO)March 23, 2023 | usnews.comPhoenix Union Bioscience High SchoolMarch 20, 2023 | marketwatch.comGlobal "Diagnostics PCR Market" 2023: On-going Trends and Growth Insights by 2027February 1, 2023 | finanznachrichten.deMeridian Bioscience, Inc.: SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian BioscienceFebruary 1, 2023 | finance.yahoo.comMeridian Bioscience finalizes $1.53B sale to South Korean-based firmsJanuary 31, 2023 | finance.yahoo.comSD Biosensor and SJL Partners Complete Transaction to Acquire Meridian BioscienceDecember 29, 2022 | benzinga.comMeridian Bioscience's Return On Capital Employed OverviewDecember 13, 2022 | seekingalpha.comMeridian Biosciences: Why I Moved On But May Go Back InDecember 12, 2022 | finance.yahoo.comMeridian Bioscience Announces Anticipated Closing Date of the Pending MergerDecember 12, 2022 | finance.yahoo.comMeridian Bioscience sets closing date for $1.53 billion dealNovember 22, 2022 | seekingalpha.comMeridian Bioscience Non-GAAP EPS of $0.21, revenue of $65.67MNovember 22, 2022 | finance.yahoo.comMeridian Bioscience (VIVO) Q4 Earnings Surpass EstimatesNovember 17, 2022 | finance.yahoo.comBellRing Brands (BRBR) Beats Q4 Earnings EstimatesOctober 15, 2022 | uk.finance.yahoo.comMeridian Bioscience, Inc. (VIVO)September 28, 2022 | msn.comVivo X Fold Plus launched: Check price, specifications and other detailsSee More Headlines Receive VIVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Meridian Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/12/2021Today4/25/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryHealth Care Supplies Current SymbolNASDAQ:VIVO CUSIP58958410 CIK794172 Webwww.meridianbioscience.com Phone(513) 271-3700Fax513-271-3762Employees702Year Founded1977Profitability EPS (Most Recent Fiscal Year)$0.97 Trailing P/E Ratio35.02 Forward P/E Ratio40.93 P/E GrowthN/ANet Income$42.46 million Net Margins12.70% Pretax Margin16.31% Return on Equity16.74% Return on Assets13.09% Debt Debt-to-Equity Ratio0.07 Current Ratio3.63 Quick Ratio2.46 Sales & Book Value Annual Sales$333.02 million Price / Sales4.49 Cash Flow$1.78 per share Price / Cash Flow19.13 Book Value$8.41 per share Price / Book4.04Miscellaneous Outstanding Shares44,010,000Free Float42,996,000Market Cap$1.50 billion OptionableOptionable Beta0.23 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesJohn Patrick KennyChief Executive Officer & Executive DirectorAndrew S. KitzmillerChief Financial Officer & Executive Vice PresidentJulie SmithChief Accounting Officer, Senior VP & ControllerEmerson C. MoserSenior Vice President & General CounselLourdes WeltzienExecutive Vice President-Life ScienceKey CompetitorsHeskaNASDAQ:HSKAOxford Immunotec GlobalNASDAQ:OXFDQuidelOrthoNASDAQ:QDELNeogenNASDAQ:NEOGMyriad GeneticsNASDAQ:MYGNView All Competitors VIVO Stock Analysis - Frequently Asked Questions How were Meridian Bioscience's earnings last quarter? Meridian Bioscience, Inc. (NASDAQ:VIVO) posted its quarterly earnings results on Friday, November, 12th. The company reported $0.24 EPS for the quarter, topping analysts' consensus estimates of $0.21 by $0.03. The company had revenue of $76.20 million for the quarter, compared to analysts' expectations of $68.40 million. Meridian Bioscience had a net margin of 12.70% and a trailing twelve-month return on equity of 16.74%. During the same quarter in the previous year, the firm posted $0.19 EPS. What is Jack Kenny's approval rating as Meridian Bioscience's CEO? 7 employees have rated Meridian Bioscience Chief Executive Officer Jack Kenny on Glassdoor.com. Jack Kenny has an approval rating of 56% among the company's employees. This puts Jack Kenny in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Meridian Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Meridian Bioscience investors own include AbbVie (ABBV), NVIDIA (NVDA), Advanced Micro Devices (AMD), Micron Technology (MU), Pfizer (PFE), AT&T (T), Gilead Sciences (GILD), Amgen (AMGN), Alibaba Group (BABA) and Tesla (TSLA). Does Meridian Bioscience have any subsidiaries? The following companies are subsidiares of Meridian Bioscience: Exalenz Bioscience.Read More This page (NASDAQ:VIVO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Meridian Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
